Pixelgen Technologies has emerged from stealth with a mission to bring a new dimension to single-cell spatial proteomics.
The launch follows the close of an approximate $6 million seed round, led by Navigare Ventures, which will support the commercialization next year of the company’s molecular pixelation technology for spatial analyses of cell surface proteins in 3D.
“We are pioneering a completely new approach to spatial proteomics with molecular pixelation, which we view as a long-term foundational technology for spatial biology in cells and tissue,” said co-founder and CEO Simon Fredriksson.
“There are massive gaps in our understanding of cellular activity, and we aim to close those gaps by offering an unprecedented view of cell-surface proteins and their spatial inter-relationships.”
Understanding cellular activity
Significant cell mapping efforts have focused on the gene expression of single cells. Yet, cell function and activity are primarily governed by the spatial orchestration of cell surface proteins, particularly immune cells.
Understanding cellular activity through the spatial organization of proteins remains largely uncharted because current tools cannot identify many proteins simultaneously and map their spatial inter-relationships.
The post Pixelgen Technologies emerges to advance single-cell spatial proteomics appeared first on Labiotech.eu.
(C) Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.